• Home
  • WEE1 kinase is a therapeutic vulnerability in CIC-DUX4 undifferentiated sarcoma.

WEE1 kinase is a therapeutic vulnerability in CIC-DUX4 undifferentiated sarcoma.

Author List
Ponce RKM, Thomas NJ, Bui NQ, Kondo T, Okimoto RA
Publication
JCI insight
Publication ID (Profile URL)
https://researcherprofiles.org/profile/276277439
Publication Year
2022
PubMed ID
35315355
Publication Title
Ponce RKM, Thomas NJ, Bui NQ, Kondo T, Okimoto RA. WEE1 kinase is a therapeutic vulnerability in CIC-DUX4 undifferentiated sarcoma. JCI Insight. 2022 03 22; 7(6).